All Stories

  1. Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
  2. Case Report: A Migrating Stitch in a Crohn’s Disease Patient
  3. The Use of Peppermint Oil in Gastroenterology
  4. Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care
  5. Intravenous Magnesium – Lidocaine - Ketorolac Cocktail for Postoperative Opioid Resistant Pain: A Case Series of Novel Rescue Therapy
  6. Management of Leaks Following Laparoscopic Sleeve Gastrectomy Using Specifically Designed Large Covered Metal Stents
  7. SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience
  8. Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems
  9. Metabolic Benefits of Probiotic Combination with Absorbent Smectite in type 2 Diabetes Patients a Randomised Controlled Trial
  10. Preface
  11. The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation
  12. Analysis of Nonsteroidal Anti-inflammatory Drugs by using Microfluidic Techniques: A Review
  13. Anti-Toxoplasmic Immunoglobulin G Quantitation Correlates with Immunovirological Parameters of HIV-Infected Cameroonians
  14. Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access
  15. Neonatal Hyperbilirubinemia: An Updated Appraisal of National Guidelines
  16. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives
  17. Focus on Phytochemical and Pharmacological Profile of Prunus lycioides (=Amygdalus lycioides)
  18. Indications for Non-Invasive Ventilation in Respiratory Failure
  19. Management of Gastrointestinal Bleeding in Rendu-Osler Disease
  20. Liver Cirrhosis Complications Management at the Emergency Department
  21. Disk Battery Ingestion: A Simple User-Guide
  22. Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1
  23. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding
  24. Management of Pleural Effusions in the Emergency Department
  25. Clinical Management of Infectious Diarrhea
  26. Honey Against Radiation-induced Oral Mucositis in Head and Neck Cancer Patients. An Umbrella Review of Systematic Reviews and Meta- Analyses of the Literature
  27. An Approach to Diabetic Ketoacidosis in an Emergency Setting
  28. Bedside Cardiac Pocus in Emergency Setting: A Practice Review
  29. Gut Alterations in Septic Patients: A Biochemical Literature Review
  30. New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases
  31. The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review
  32. Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?
  33. Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells
  34. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors
  35. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
  36. Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia?
  37. Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship
  38. Dealing with COVID-19: lessons learned from the Italian experience
  39. The Deadly Quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high
  40. Electrophysiological and Clinical Improvement in Non-Invasive Treatment of Carpal Tunnel Syndrome
  41. Smart Nanocarriers for Targeted Cancer Therapy
  42. Circadian rhythms of endothelial nitric oxide synthase and toll-like receptors 2 production in females with rheumatoid arthritis depending on NOS3 gene polymorphism
  43. Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey
  44. Preface
  45. A Hazelnut-Enriched Diet Modulates Oxidative Stress and Inflammation Gene Expression without Weight Gain
  46. Olive oil antioxidants and non-alcoholic fatty liver disease
  47. Effect of Chondroitin Sulfate on Blood Serum Cytokine Profile during Carrageenan-induced Edema and Monoiodoacetate-induced Osteoarthritis in Rats
  48. Preface
  49. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
  50. Rosmarinic Acid as Potential Anti-Inflammatory Agent
  51. A Systematic Review on Natural Antioxidant Properties of Resveratrol
  52. Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
  53. Basics in Endoscopic Ultrasound Part 2: EUS-guided Sampling and Therapeutic Applications
  54. Resistin levels in non-alcoholic fatty liver disease pathogenesis
  55. Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: a Case-Control Study
  56. Basics in Endoscopic Ultrasound Part 1: Diagnostic Indications and Tissue Sampling
  57. The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence
  58. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
  59. Gut microbiota changes and chronic hepatitis C virus infection
  60. Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance
  61. Polyphenols treatment in patients with nonalcoholic fatty liver disease
  62. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders
  63. Editorial (Thematic Issue: Alcoholic Liver Disease: From Bench to Bedside)
  64. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
  65. Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship
  66. Estimation of in vivo and in vitro exposure to bisphenol A as food contaminant
  67. Meet Our Editorial Board Member:
  68. Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia
  69. The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
  70. Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
  71. Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice
  72. Non Alcoholic Fatty Liver: Epidemiology and Natural History
  73. non-alcoholic fatty liver disease
  74. Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease
  75. Non-alcoholic fatty liver disease and beneficial effects of dietary supplements
  76. Adiponectin serum level in chronic hepatitis C infection and therapeutic profile
  77. C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention
  78. Enhanced Expression of Indoleamine 2,3-Dioxygenase inHelicobacter pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production
  79. Su1939 Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production
  80. 1028 High Exposure, Spontaneous Clearance and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study
  81. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
  82. Pharmacotherapy of acute alcoholic hepatitis in clinical practice
  83. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
  84. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
  85. Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation
  86. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
  87. Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
  88. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
  89. Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center
  90. Dietary Intervention in Non-Alcoholic Fatty Liver Disease
  91. Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
  92. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study
  93. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease
  94. Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
  95. Helicobacter species and liver disease
  96. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease
  97. Bone Mineralization in Celiac Disease
  98. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease
  99. Adiponectin levels in nonalcoholic fatty liver disease
  100. Transient Elastography for Assessment of Non-Alcoholic Fatty Liver Disease
  101. Insulin resistance increases risk of carpal tunnel syndrome: a case-control study
  102. Chronic hepatitis C infection and insulin resistance: two best friends
  103. “. . . and Suddenly a Tree!”
  104. Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease
  105. Non-alcoholic fatty liver disease and pharmacological options
  106. Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa
  107. Milk thistle in liver diseases: past, present, future
  108. Metformin: A Therapeutic Option for Treating Nonalcoholic Fatty Liver Disease
  109. Brain hypoperfusion and neurological symptoms in celiac disease
  110. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
  111. Nervous system in the gluten syndrome: A close relationship
  112. Celiac disease: from gluten to skin
  113. Behçet’s disease and celiac disease: a rare association or a possible link?
  114. Phytotherapeutic approach to alcohol dependence: New old way?
  115. Subclinical Neurological Abnormalities and Gluten-Free Diet
  116. Acute alcohol intoxication
  117. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
  118. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting
  119. Subclinical Neurological Abnormalities in Patients With Celiac Disease: Are They Associated by Brain Hypoperfusion?
  120. Complementary therapies for treating alcoholism
  121. Elastography assessment in patients with chronic HCV infection
  122. Intestinal Malabsorption and Skin Diseases
  123. Affective and Psychiatric Disorders in Celiac Disease
  124. Probiotics: Which and When?
  125. Metabolic and Nutritional Features in Adult Celiac Patients
  126. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
  127. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study
  128. Neuroendocrine and Psychological Assessment in a Guinness 10 Days Scuba Dive
  129. Analysis of the T1288R Mutation of the Wilson Disease ATP7B Gene in Four Generations of a Family: Possible Genotype-Phenotype Correlation with Hepatic Onset
  130. Celiac disease and skin: Psoriasis association
  131. Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients
  132. Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
  133. Complementary medicine for alcohol dependence in Italian services: A mail questionnaire
  134. Primary renal angiosarcoma: A rare malignancy. A case report and review of the literature☆
  135. Genotype–phenotype correlation of the Wilson diseaseATP7B gene
  136. Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam
  137. A New Mutation of Wilson's Disease P-Type ATPase Gene in a Patient with Cirrhosis and Coombs-Positive Hemolytic Anemia
  138. Neurobiochemical and clinical aspects of craving in alcohol addiction: A review
  139. CELIAC DISEASE AND SKIN DISORDERS
  140. Psychological Support Counseling: A New Strategy to Increase Gluten-Free Diet Compliance in Celiac Patients
  141. Association between psoriasis and coeliac disease
  142. Suppression of Craving for ??-Hydroxybutyric Acid by Naltrexone Administration
  143. Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage
  144. How Many Cravings? Pharmacological Aspects of Craving Treatment in Alcohol Addiction: A Review
  145. Neurologic Disorders in Patients With Celiac Disease: Are They Mediated by Brain Perfusion Changes?
  146. Tolerance to baclofen?s sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence
  147. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders
  148. Gluten-related cerebral hypoperfusion and neurologic disorders in coeliac patients
  149. Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report
  150. Rapid Regression of Psoriasis in a Coeliac Patient after Gluten-Free Diet
  151. Baclofen: clinical data